Miami, FL
Joined May 2010
- Tweets340
- Following65
- Followers235
- Likes834
Amer Beitinjaneh, MD, MSc, MPH, FACP retweeted
The 2026 Whistler DAVA Summit on Hematological Malignancies has come to a close. We extend our gratitude to all participants for their valuable insights, expertise, and engaging questions and answers. #DAVAWhistler
Amer Beitinjaneh, MD, MSc, MPH, FACP retweeted
Starting Now: Emerging CAR-T Therapies in T-cell Lymphomas
Moderated by: Dr. Stephen Schuster @PennMedicine
#DAVAWhistler
Happy to be at Dava Oncology. Next 5 years will show whether CAR-T becomes a true paradigm shift in autoimmune diseases.
Anti-CD19 CAR-T demonstrates a manageable safety profile with reversible TEAEs and reductions in disease activity across SLE, SSc, and IIM; 91.6% of patients remained off therapy up to ~18 months, supporting potential for immune reset. Dr. @abeitin @umiamimedicine #DAVAWhistler
Amer Beitinjaneh, MD, MSc, MPH, FACP retweeted
Anti-CD19 CAR-T demonstrates a manageable safety profile with reversible TEAEs and reductions in disease activity across SLE, SSc, and IIM; 91.6% of patients remained off therapy up to ~18 months, supporting potential for immune reset. Dr. @abeitin @umiamimedicine #DAVAWhistler
Amer Beitinjaneh, MD, MSc, MPH, FACP retweeted
Our stem cell transplant and cellular therapy program has earned designation as a Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Core Center. At the same time, the program is expanding access to care with the opening of a new outpatient satellite at University of Miami Health System SoLé Mia. 🙌
Dr. Amer Beitinjaneh serves as Sylvester’s site PI for the NHLBI-funded BMT CTN Core Center grant. His national collaborations and long-standing work with the BMT CTN helped position Sylvester for this designation and ongoing @NIH network participation. Learn more: loom.ly/2qDC1m0
Honored to be promoted to Full Professor of Medicine. I’m deeply thankful to my collaborators and colleagues for their support throughout this journey. I look forward to continuing to advance clinical care, research, and education.
Happy to share our NEJM publication on the FELIX study that led to the FDA approval of Obe-cel for R/R B-ALL @SylvesterCancer @UMiamiHealth
Results of the FELIX trial of obe-cel in R/R B-ALL now out @NEJM. #TcellRx #leusm
➡️ 127 pts
➡️ mEFS 11.9 mo, mOS 15.6 mo
➡️ 2.4% G3+ CRS, 7.1% G3+ ICANS!
➡️ Survival curve plateau! but limited # in longer f/u
➡️ high tumor burden still a challenge
nejm.org/doi/full/10.1056/NE… $AUTL
I’m happy to have led the FELIX registrational study @SylvesterCancer that resulted in the FDA approval of obecabtagene autoleucel today for R/R B Cell ALL.
Thank U @MKD_BMT @Mohty_EBMT for the invitation to be on the faculty at the IACH meeting in Paris to share our update on the management of R/R mantle cell lymphoma. @SylvesterCancer.Truly impressed by the meeting agenda and organization. Looking forward to next year’s meeting.
Outstanding presentation on management of relapsed/refractory mantle cell lymphoma by @abeitin at 2024 @TheIACH @COLYMCongress in #Paris @MediHumdani @Mohty_EBMT @AnnaSureda5 @StefanoLuminari
Amer Beitinjaneh, MD, MSc, MPH, FACP retweeted
CONGRESS | @TheIACH #IACH2024 | PRESENTATION
Amer Beitinjaneh @abeitin @univmiami @SylvesterCancer discusses the management of patients with R/R mantle cell lymphoma.
They highlight the role of BTK inhibitors, CAR T-cell therapies, transplantation, and novel therapies in the R/R setting.
Follow our live feed for more updates: lymphomahub.com/medical-info…
#lymphoma #lymsm #MedicalCongress
Amer Beitinjaneh, MD, MSc, MPH, FACP retweeted
If you are in the South Florida area, come check this dinner program out.
Thursday 9/5/24 5pm-9pm @ Sunrise, FL
@FLASCO_ORG
members.flasco.org/calendaro…
Amer Beitinjaneh, MD, MSc, MPH, FACP retweeted
@RickLin_ @ASTCT #IDTwitter #CMV #immunotherapy #tcellrx #lymphoma @SylvesterCancer @abeitin @amjimenezmd
CMV reactivation is a common complication of CAR T-cell therapy and is associated with increased overall mortality. ow.ly/uOfi50SMvUY #immunobiologyandimmunotherapy #healthservicesandoutcomes
Amer Beitinjaneh, MD, MSc, MPH, FACP retweeted
Great speaking to @Blood_Cancers about our multi-center effort investigating outcomes of HSCT in Hepatosplenic T cell lymphoma @DholariaMD @sairah__ahmed @AlhajMoustafa @abeitin @DeepJagMD @DrAmbuj @MKD_BMT @MayoCancerCare
pubmed.ncbi.nlm.nih.gov/3843…
Last week, @hemant_murthy, of @MayoCancerCare, stopped by BCT to talk about his recent study on #HSCT outcomes in patients with hepatosplenic T-cell lymphoma.
➡️ Watch here! buff.ly/3zBLnNT
Happy to see Tab-cel BLA being submitted based on the ALLELE study we presented this year. cgtlive.com/view/atara-submi….
Today we celebrate our amazing TCT team ( thx to @drkomanduri ) and welcome our new Chief, Dr. Damian Green @SylvesterCancer @UMiamiHealth
Delighted to share my perspective on the lessons learned from the success of cellular therapy in Hematology and how to apply them to address the pressing needs in Solid Tumor treatment. @SylvesterCancer
#MPM2024 Very excited to meet @abeitin (in person - not on zoom) @sylvestercancer and listen to his great talk on the brave new world and Landscape of Adoptive Immunotherapy in Solid Tumors.
➡️ the future of #TILs and #CAR-T is already here.
➡️We have active clinical trials enrolling pts w solid tumors @SylvesterCancer
2nd Biennnial Miami Precision Medicine Conference
Amer Beitinjaneh, MD, MSc, MPH, FACP retweeted
He did the same with insulin. Relentless pressure to help patients. All 3 major insulin manufacturers cut their prices this year.
Amer Beitinjaneh, MD, MSc, MPH, FACP retweeted
Be a part of the symphony of lifesavers that helps patients get the blood stem cell transplants they need. #JoinTheSymphony with us, @MichelleObama, @BarackObama, @JonBatiste, @suleikajaouad, @MattHeineman, & @nmdp_org by learning how you can help 👉 bit.ly/3N4HyVg
Amer Beitinjaneh, MD, MSc, MPH, FACP retweeted
Congrats to @SylvesterCancer and Dr. Green and wishing them great success in expanding access and outcomes for cell therapy patients in South Florida and beyond. #bmtsm – at San Francisco, CA
We’re thrilled to welcome Damian Green, pioneering #immunotherapy & #MultipleMyeloma researcher and physician, as our new chief of Transplantation & Cellular Therapy and assistant director of Translational Research. Welcome to the team, Dr. Green! 🙌 loom.ly/rZ-xztw
